SBI-115

Pharmaceutical compound From Wikipedia, the free encyclopedia

SBI-115 is an experimental drug which acts as a potent and selective antagonist for the G protein-coupled bile acid receptor (GPBAR1/TGR5). It is used for studying the function of this receptor, and has been found to show beneficial effects in animal models of polycystic liver disease as well as some forms of cancer.[1][2][3][4][5]

CAS Number
FormulaC14H13ClN2O4S
Quick facts Identifiers, CAS Number ...
SBI-115
Identifiers
  • (3-methylphenyl) 5-chloro-2-ethylsulfonylpyrimidine-4-carboxylate
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC14H13ClN2O4S
Molar mass340.78 g·mol−1
3D model (JSmol)
  • CCS(=O)(=O)C1=NC=C(C(=N1)C(=O)OC2=CC=CC(=C2)C)Cl
  • InChI=1S/C14H13ClN2O4S/c1-3-22(19,20)14-16-8-11(15)12(17-14)13(18)21-10-6-4-5-9(2)7-10/h4-8H,3H2,1-2H3
  • Key:IJPXOPBVXVPPEW-UHFFFAOYSA-N
Close

References

Related Articles

Wikiwand AI